Home/Filings/4/0001731122-24-002045
4//SEC Filing

Boenisch Sandra 4

Accession 0001731122-24-002045

CIK 0001314052other

Filed

Dec 22, 7:00 PM ET

Accepted

Dec 23, 7:00 PM ET

Size

5.8 KB

Accession

0001731122-24-002045

Insider Transaction Report

Form 4
Period: 2024-12-19
Boenisch Sandra
PFO & Treasurer
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-12-19+12,50012,500 total
    Exercise: $5.36From: 2024-12-19Exp: 2034-02-20Common Stock (12,500 underlying)
Footnotes (1)
  • [F1]On February 20, 2024, the reporting person was granted an option to purchase 50,000 shares of common stock. The option vests in four equal tranches based on four performance milestones, one of which was regulatory submission of AD-004 for Alzheimer's disease (US or EU). The performance criteria for this milestone was met with the acceptance of the MAA filing by the EMA, resulting in vesting of the option as to 12,500 shares.

Documents

1 file

Issuer

ANAVEX LIFE SCIENCES CORP.

CIK 0001314052

Entity typeother

Related Parties

1
  • filerCIK 0001655366

Filing Metadata

Form type
4
Filed
Dec 22, 7:00 PM ET
Accepted
Dec 23, 7:00 PM ET
Size
5.8 KB